beta
NVLN
Novelion Therapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Novelion Therapeutics Inc is a biopharmaceutical company. It is engaged in developing patient care facility and providing services for people suffering from rare diseases like lipodystrophy, leber congenital amaurosis, and retinitis pigmentosa.
Market Cap: 83.3 Million
Primary Exchange: Nasdaq Global Select
Website: http://www.novelion.com
Shares Outstanding: 18.6 Million
Float: 17.7 Million
Dividend: 0.0 (0.0%)
Beta: -0.026084
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1696 trading days
From: 2013-04-01 To: 2019-10-08
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-12-19 | 5.0 | 1.0 | 5.0 |